منابع مشابه
Circulatory YKL-40 & NLR: Underestimated Prognostic Indicators in Diffuse Glioma
In addition to histopathological parameters, evaluation of associated hematological factors is essential for devising a sensitive prognostic scale in glioma. Increased neutrophil-lymphocyte ratio (NLR), a marker of systemic inflammatory response, has recently been associated with worse outcome in various cancers. Given that glioma progression is characterized by inflammation, aggressive angioge...
متن کاملDiffuse brainstem glioma: prognostic factors.
OBJECT Brainstem gliomas were regarded as a single entity prior to the advent of MRI; however, several studies investigating MRI have recognized that these lesions are a heterogeneous group, and certain subgroups have a better prognosis for long-term survival. The aim of this study was to conduct a retrospective analysis of prognostic factors of patients with brainstem gliomas confirmed by hist...
متن کاملMR imaging of diffuse glioma.
Neuroradiologic diagnosis of "gliomatosis cerebri" is hampered by the diffuse, isodense character of the lesion, and the fact that it may not enhance when intravenous contrast medium is administered. Clinical signs and symptoms are usually nonspecific, nonfocal, and disproportionately mild. We report a case of diffuse glioma in a 30-year-old man, discuss the difficulty in arriving at a precise ...
متن کاملIntramedullary diffuse tubercular lesion resembling glioma.
Sir, Of the various forms of spinal tuberculosis, intramedullary spinal tuberculomas (IMT) are least common (2/100,000 of all tuberculosis).1 We recently encountered a case, which was diagnosed as glioma after imaging was done, leading to neurosurgical intervention, which later turned out to be a tubercular lesion. This case report underscores the importance of keeping a high degree of suspicio...
متن کاملNanotechnology Applications for Diffuse Intrinsic Pontine Glioma
Diffuse intrinsic pontine gliomas (DIPGs) are invariably fatal tumors found in the pons of elementary school aged children. These tumors are grade II-IV gliomas, with a median survival of less than 1 year from diagnosis when treated with standard of care (SOC) therapy. Nanotechnology may offer therapeutic options for the treatment of DIPGs. Multiple nanoparticle formulations are currently being...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Acta Neuropathologica
سال: 2007
ISSN: 0001-6322,1432-0533
DOI: 10.1007/s00401-007-0293-7